Article thumbnail

An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin

By Ainhoa Ruiz-Aracama, Ad Peijnenburg, Jos Kleinjans, Danyel Jennen, Joost van Delft, Caroline Hellfrisch and Arjen Lommen
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3141663
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2003). A: Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard with their biotransformation properties. Drug Metab Dispos
  2. (2002). An EU perspective on the use of in vitro methods in regulatory pharmaceutical toxicology. Toxicol Lett
  3. (1991). Bunce NJ: The Ah receptor and the mechanism of dioxin toxicity.
  4. (2010). Delft JHM: Comparison of HepG2 and HepaRG by Whole-Genome Gene Expression Analysis for the Purpose of Chemical Hazard Identification. Toxicol Sci
  5. (2005). Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology.
  6. (2009). EU research activities in alternative testing strategies: current status and future perspectives. Arch Toxicol
  7. (2002). Genomics: an in vitro toxicology point of view. Altern Lab Anim
  8. (2002). HG: Dioxin Increases Reactive Oxygen Production in Mouse Liver Mitochondria. Toxicol Appl Pharmacol
  9. (2007). Hoogenboom LAP, Nielen MWF: An untargeted metabolomics approach to contaminant analysis: Pinpointing potential unknown compounds. Anal Chim Acta
  10. (1982). JC: 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity. Annu Rev Pharmacol Toxicol
  11. (2008). JK: NMR-Based Metabolic Profiling and Metabonomic Approaches to Problems in Molecular Toxicology. Chem Res Toxicol
  12. (2009). Keun HC: Effect of the Histone Deacetylase Inhibitor Trichostatin A on the Metabolome of Cultured Primary Hepatocytes. J Proteome Res
  13. (2005). Kleinjans JCS: Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. Mutat Res, Fundam Mol Mech Mutagen
  14. (2004). Kleinjans JCS: Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. Carcinogenesis
  15. LK: Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.
  16. (2000). Medvedovic M: The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem Pharmacol
  17. (2008). Metabolomics-assisted breeding: a viable option for crop improvement? Trends Genet
  18. (2008). Metabolomics: A Global Biochemical Approach to Drug Response and Disease. Annu Rev Pharmacol Toxicol
  19. (1999). Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica
  20. (2009). MetAlign: Interface-Driven, Versatile Metabolomics Tool for Hyphenated Full-Scan Mass Spectrometry Data Preprocessing. Anal Chem
  21. (2001). Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett
  22. (1998). Natajaran AT: Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat Res, Fundam Mol Mech Mutagen
  23. (2004). Nebert DW: Cyp1a1(-/-) male mice: protection against highdose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria. Toxicol Appl Pharmacol
  24. (2009). NMR metabolomics and drug discovery. Magn Reson Chem
  25. (1998). On the detection of environmental effects on complex matrices combining off-line liquid chromatography and 1H-NMR. Biodegradation
  26. (2007). RD: Untargeted large-scale plant metabolomics using liquid chromatography coupled to mass spectrometry. Nat Protoc
  27. (2009). Sachinidis A: The Potential of Embryonic Stem Cells Combined with -omics Technologies as Model Systems for Toxicology. Curr Med Chem
  28. (1995). The Aryl Hydrocarbon Receptor Complex. Annu Rev Pharmacol Toxicol
  29. (1998). TP: Dioxin Causes a Sustained Oxidative Stress Response in the Mouse. Biochem Biophys Res Commun
  30. (2006). Understanding mouse models of disease through metabolomics. Curr Opin Chem Biol